Literature DB >> 17996986

The complex roles of neurosteroids in depression and anxiety disorders.

Patrizia Longone1, Rainer Rupprecht, Gaia A Manieri, Giorgio Bernardi, Elena Romeo, Augusto Pasini.   

Abstract

The role of neurosteroids in neuropsychiatric disorders has been thoroughly investigated in many research studies that have stressed their significant pathophysiological function in neuropsychiatry. In this review, we will focus mainly on the steroids active on the GABA(A) receptors studied in anxiety and depression. The aim is to discuss the controversial results reported in research on anxiety and depressive disorders. We suggest the combined use of biological parameters linked to psychopathological dimensions to make more homogeneous diagnoses and to develop more precise therapies for the treatment of depression and anxiety disorders. We discuss the role of neurosteroids in the pathophysiology and therapy of anxiety and depression. Finally, we consider the possibility of using quantification of mRNA expression of steroidogenic enzymes from peripheral sources in neuropsychiatry.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996986     DOI: 10.1016/j.neuint.2007.10.001

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  19 in total

1.  Prevalence, incidence, and persistence of psychiatric and substance use disorders among mothers living with HIV.

Authors:  Kathleen M Malee; Claude A Mellins; Yanling Huo; Katherine Tassiopoulos; Renee Smith; Patricia A Sirois; Susannah M Allison; Deborah Kacanek; Suad Kapetanovic; Paige L Williams; Mitzie L Grant; Daniel Marullo; Angela A Aidala
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

2.  5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients.

Authors:  Roberto Carlos Agis-Balboa; Alessandro Guidotti; Graziano Pinna
Journal:  Psychopharmacology (Berl)       Date:  2014-04-30       Impact factor: 4.530

3.  The antidepressant-like effect of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane involves a regulation of β-type estrogen receptors.

Authors:  Julie Espallergues; Jamal Temsamani; Claude Laruelle; Alexandre Urani; Tangui Maurice
Journal:  Psychopharmacology (Berl)       Date:  2010-10-28       Impact factor: 4.530

4.  Association of the GABRD gene and childhood-onset mood disorders.

Authors:  Y Feng; K Kapornai; E Kiss; Z Tamás; L Mayer; I Baji; G Daróczi; I Benák; V O Kothencné; E Dombovári; E Kaczvinszk; M Besnyo; J Gádoros; J Székely; M Kovacs; A Vetró; J L Kennedy; C L Barr
Journal:  Genes Brain Behav       Date:  2010-06-18       Impact factor: 3.449

5.  Developmentally regulated neurosteroid synthesis enhances GABAergic neurotransmission in mouse thalamocortical neurones.

Authors:  Adam R Brown; Murray B Herd; Delia Belelli; Jeremy J Lambert
Journal:  J Physiol       Date:  2014-12-03       Impact factor: 5.182

6.  A mutant residue in the third transmembrane region of the GABA(A) alpha1 subunit causes increased agonistic neurosteroid responses.

Authors:  Daniel B Williams
Journal:  Neurochem Int       Date:  2011-03-21       Impact factor: 3.921

7.  GABA(A)R plasticity during pregnancy: relevance to postpartum depression.

Authors:  Jamie Maguire; Istvan Mody
Journal:  Neuron       Date:  2008-07-31       Impact factor: 17.173

8.  Steroid hormone fluctuations and GABA(A)R plasticity.

Authors:  Jamie Maguire; Istvan Mody
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

Review 9.  Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice.

Authors:  Graziano Pinna; Roberto Carlos Agis-Balboa; Fabio Pibiri; Marianela Nelson; Alessandro Guidotti; Erminio Costa
Journal:  Neurochem Res       Date:  2008-05-13       Impact factor: 3.996

Review 10.  A reproductive subtype of depression: conceptualizing models and moving toward etiology.

Authors:  Jennifer L Payne; Jennifer Teitelbaum Palmer; Hadine Joffe
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.